168 related articles for article (PubMed ID: 17639507)
1. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.
Brown MD; Gilmore PE; Hart CA; Samuel JD; Ramani VA; George NJ; Clarke NW
Prostate; 2007 Sep; 67(13):1384-96. PubMed ID: 17639507
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of CD133+ and CD133- epithelial cells from human prostate.
Shepherd CJ; Rizzo S; Ledaki I; Davies M; Brewer D; Attard G; de Bono J; Hudson DL
Prostate; 2008 Jun; 68(9):1007-24. PubMed ID: 18398820
[TBL] [Abstract][Full Text] [Related]
5. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
6. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
[TBL] [Abstract][Full Text] [Related]
7. ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate.
Mathew G; Timm EA; Sotomayor P; Godoy A; Montecinos VP; Smith GJ; Huss WJ
Cell Cycle; 2009 Apr; 8(7):1053-61. PubMed ID: 19270533
[TBL] [Abstract][Full Text] [Related]
8. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
[TBL] [Abstract][Full Text] [Related]
9. Novel method for the isolation and characterisation of the putative prostatic stem cell.
Bhatt RI; Brown MD; Hart CA; Gilmore P; Ramani VA; George NJ; Clarke NW
Cytometry A; 2003 Aug; 54(2):89-99. PubMed ID: 12879455
[TBL] [Abstract][Full Text] [Related]
10. CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.
Yamamoto H; Masters JR; Dasgupta P; Chandra A; Popert R; Freeman A; Ahmed A
PLoS One; 2012; 7(10):e46979. PubMed ID: 23071686
[TBL] [Abstract][Full Text] [Related]
11. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
[TBL] [Abstract][Full Text] [Related]
12. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.
Taylor RA; Toivanen R; Frydenberg M; Pedersen J; Harewood L; ; Collins AT; Maitland NJ; Risbridger GP
Stem Cells; 2012 Jun; 30(6):1087-96. PubMed ID: 22593016
[TBL] [Abstract][Full Text] [Related]
13. CD133, a novel marker for human prostatic epithelial stem cells.
Richardson GD; Robson CN; Lang SH; Neal DE; Maitland NJ; Collins AT
J Cell Sci; 2004 Jul; 117(Pt 16):3539-45. PubMed ID: 15226377
[TBL] [Abstract][Full Text] [Related]
14. Prostate-regenerating capacity of cultured human adult prostate epithelial cells.
Yao M; Taylor RA; Richards MG; Sved P; Wong J; Eisinger D; Xie C; Salomon R; Risbridger GP; Dong Q
Cells Tissues Organs; 2010; 191(3):203-12. PubMed ID: 19776547
[TBL] [Abstract][Full Text] [Related]
15. Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers.
Oates JE; Grey BR; Addla SK; Samuel JD; Hart CA; Ramani VA; Brown MD; Clarke NW
Stem Cells Dev; 2009 Dec; 18(10):1515-22. PubMed ID: 19260804
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells.
Addla SK; Brown MD; Hart CA; Ramani VA; Clarke NW
Am J Physiol Renal Physiol; 2008 Sep; 295(3):F680-7. PubMed ID: 18614618
[TBL] [Abstract][Full Text] [Related]
17. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
Guzmán-Ramírez N; Völler M; Wetterwald A; Germann M; Cross NA; Rentsch CA; Schalken J; Thalmann GN; Cecchini MG
Prostate; 2009 Nov; 69(15):1683-93. PubMed ID: 19644960
[TBL] [Abstract][Full Text] [Related]
18. Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells.
Budak MT; Alpdogan OS; Zhou M; Lavker RM; Akinci MA; Wolosin JM
J Cell Sci; 2005 Apr; 118(Pt 8):1715-24. PubMed ID: 15811951
[TBL] [Abstract][Full Text] [Related]
19. Electron Microscopic Analysis of Stem Cells in Human Prostate Cancer, Including Inverted Capsule Embedding Methods for Archival Sections and Falcon Films for Prostate Cancer Cell Lines.
Sinha AA
Anticancer Res; 2019 Aug; 39(8):4171-4177. PubMed ID: 31366502
[TBL] [Abstract][Full Text] [Related]
20. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
Heer R; Robson CN; Shenton BK; Leung HY
J Cell Physiol; 2007 Sep; 212(3):572-8. PubMed ID: 17541959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
